[TEVA] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[TEVA] Teva Pharmaceutical Industries Limited
Announcement Date
02-Nov-2017
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- -2,276.42%
YoY- -1,085.51%
Quarter Report
TEVA's Result
TEVA's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 4,452,000 4,468,000 4,559,000 5,459,000 6,492,000 4,881,000 5,168,000 -2.45%
PBT 137,000 -38,000 -3,387,000 -13,208,000 -914,000 861,000 872,000 -26.52%
Tax -21,000 -119,000 -139,000 -1,471,000 57,000 249,000 186,000 -
NP 150,000 109,000 -2,886,000 -11,535,000 -973,000 500,000 687,000 -22.38%
Tax Rate 15.33% - - - - -28.92% -21.33% -
Total Cost 4,302,000 4,359,000 7,445,000 16,994,000 7,465,000 4,381,000 4,481,000 -0.67%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 3.37 2.44 -63.30 -211.30 -14.99 10.24 13.29 -20.42%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS 0.14 0.10 -2.80 -11.34 -0.96 0.56 0.80 -25.19%
EPS Diluted 0.14 0.10 -2.80 -11.34 -0.96 0.55 0.80 -25.19%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.